Press release
Glaucoma Market to Reach $12.77 Billion by 2031 | Driven by Aging Population & FDA-Approved Implants
Glaucoma Market
Market Overview
Glaucoma is a group of eye conditions causing progressive vision loss and blindness due to optic nerve damage, primarily from elevated intraocular pressure (IOP) caused by aqueous humor buildup. The market encompasses treatments like prostaglandins, beta blockers, alpha-adrenergic agonists, and implants, targeting types such as open-angle, angle-closure, and congenital glaucoma. It serves various age groups and is distributed through hospital, retail, and online pharmacies. The market is driven by the rising prevalence of glaucoma, an aging population, and advancements in treatment options, though alternative therapies pose challenges.
📌 Access valuable insights with our sample report - (Please enter your Corporate Email ID to get priority access):- https://www.datamintelligence.com/download-sample/glaucoma-market?rk
Market Opportunities
Key opportunities include developing innovative drug delivery systems like sustained-release implants, expanding access in emerging markets, and leveraging telemedicine for early diagnosis. Increased focus on combination therapies and personalized medicine also presents growth potential.
Key Trends
Growing adoption of prostaglandin analogs for effective IOP reduction.
Advancements in minimally invasive glaucoma surgery (MIGS) and implants.
Rising use of telemedicine and AI for early glaucoma detection and monitoring.
Recent Developments
December 2024: Glaukos Corporation received FDA approval for iDoseTR, a travoprost intracameral implant for sustained IOP reduction in glaucoma patients.
May 2024: The American Academy of Ophthalmology highlighted the rising prevalence of POAG, emphasizing the need for early detection and treatment advancements.
January 2024: AbbVie reported significant U.S. revenue from Lumigan and Alphagan, reinforcing North America's market dominance.
2023: Studies projected a rise to 112 million global glaucoma cases by 2040, driving demand for innovative therapies.
Market Dynamics: Drivers
Rising Prevalence of Glaucoma
The global prevalence of glaucoma, affecting approximately 80 million people in 2023 and projected to reach 112 million by 2040 (Glaucoma Research Foundation), is a major driver. The aging population, expected to reach 1.42 billion over 60 by 2030 (United Nations), is at higher risk, with 3 million cases in the U.S. alone, projected to double by 2050 (CDC). This growing burden fuels demand for effective treatments like prostaglandins and implants.
Market Dynamics: Restraints
Availability of Alternative Therapies
The rise of generic medications, non-pharmacological treatments, and alternative therapies like laser procedures and MIGS competes with traditional glaucoma drugs and surgeries. These alternatives, often more cost-effective or less invasive, can reduce adherence to conventional treatments, limiting market growth.
Market Segment Analysis
By Type: Open-Angle Glaucoma Dominates
Open-angle glaucoma (POAG) held the largest market share in 2024 due to its high prevalence (1.86% in those over 40, American Academy of Ophthalmology). POAG, affecting 3.1% in rural East African populations and 44.2% in Ghana hospital studies, drives demand for treatments due to its asymptomatic progression and chronic nature.
By Treatment Type: Prostaglandins Lead
The prostaglandin segment, including drugs like latanoprost, bimatoprost, and travoprost, dominated with a significant share in 2024 due to their efficacy in reducing IOP via uveoscleral outflow and minimal side effects. The FDA approval of Glaukos' iDoseTR travoprost implant (December 2024) highlights innovation in this segment. Alpha-adrenergic agonists are the fastest-growing segment due to their safety and advancements in delivery.
By Age Group
Geriatrics lead due to higher glaucoma risk, followed by adults, with children representing a smaller segment for congenital glaucoma.
By Distribution Channel
Hospital pharmacies dominate, followed by retail and online pharmacies, with online channels growing due to convenience.
By Region
North America holds the largest share, while Asia-Pacific is the fastest-growing region due to rising prevalence and healthcare investments.
📌 Speak to Our Senior Analyst and Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/glaucoma-market
Geographical Share
North America Holds Significant Share
North America accounted for a significant market share in 2024, driven by advanced healthcare infrastructure, high glaucoma prevalence (3 million U.S. cases, CDC), and strong revenue from branded drugs like AbbVie's Lumigan (US$ 432 million, 40% from the U.S.) and Alphagan (US$ 272 million, 45% from the U.S.). Regulatory support and awareness further bolster the region's dominance.
Asia-Pacific Grows Rapidly
Asia-Pacific is the fastest-growing region, driven by increasing glaucoma prevalence, economic development, and improved healthcare access in countries like China and India. Rising awareness and technological advancements in treatment options contribute to rapid market expansion.
📌 Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=glaucoma-market
Major Players
Key companies in the glaucoma market include:
Novartis AG
Bausch + Lomb
Viatris Inc.
AbbVie
Alcon Inc.
Thea Pharma Inc.
Pfizer Inc.
Santen Pharmaceutical Co., Ltd.
Sun Pharmaceutical Industries, Inc.
Somerset Pharma LLC
Emerging Players
Metcela Inc.
Inspira-Technologies OXY B.H.N. LTD.
LIVANOVA PLC
📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription
☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Glaucoma Market to Reach $12.77 Billion by 2031 | Driven by Aging Population & FDA-Approved Implants here
News-ID: 4172034 • Views: …
More Releases from DataM Intelligence 4market Research LLP
Metabolic Dysfunction-Associated Steatohepatitis (MASH) Treatment Market Forecas …
Market Size and Growth
The global Metabolic Dysfunction-Associated Steatohepatitis (MASH) treatment market was valued at US$ 1.67 billion in 2023 and is projected to reach US$ 7.64 billion by 2031, growing at a compound annual growth rate (CAGR) of 21.8% during the forecast period 2024-2031.
Market Overview
Metabolic Dysfunction-Associated Steatohepatitis (MASH), previously known as nonalcoholic steatohepatitis (NASH), is an advanced form of metabolic dysfunction-associated steatotic liver disease (MASLD), characterized by liver inflammation and…
Decentralized clinical trials Market Outlook 2025-2033: $8.68B to $29.9B Growth …
The global decentralized clinical trials (DCTs) market was valued at US$ 8.68 billion in 2024 and is projected to reach US$ 29.90 billion by 2033, growing at a compound annual growth rate (CAGR) of 14.8% during the forecast period 2025-2033.
Market Overview
Decentralized clinical trials (DCTs) leverage digital technologies such as telemedicine, wearable sensors, and electronic data capture (EDC) systems to conduct clinical research remotely, reducing the need for in-person site visits.…
Digital Holographic Microscopy Market Growth Driven by Pharma & Biotechnology-US …
The Digital Holographic Microscopy (DHM) market is witnessing a transformative phase, driven by the increasing demand for advanced, non-invasive imaging technologies across scientific and industrial applications. DHM, an innovative optical microscopy technique, leverages holography principles to capture high-resolution, three-dimensional images of microscopic objects without the need for staining or labeling.
This capability makes it invaluable for real-time observation of live cells, material surfaces, and microstructures, positioning DHM as a cornerstone…
North America Intravascular Ultrasound Systems Market Led by U.S. Dominance, CAG …
The North America Intravascular Ultrasound (IVUS) Systems Market is a dynamic and rapidly evolving segment of the medical imaging industry, driven by the increasing demand for advanced diagnostic tools in cardiovascular care. Intravascular ultrasound is a cutting-edge imaging technology that utilizes ultrasound waves to provide high-resolution, cross-sectional images of blood vessels, particularly coronary arteries. This technology is pivotal in interventional cardiology, offering detailed visualization of vessel walls, lumen, and plaque…
More Releases for Glaucoma
Glaucoma Surgery Devices Market Report 2024 - Glaucoma Surgery Devices Market Si …
"The Business Research Company recently released a comprehensive report on the Global Glaucoma Surgery Devices Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The glaucoma surgery devices…
Global Glaucoma Market
According to a new market research report published by Global Market Estimates, the Global Glaucoma Market is projected to grow at a CAGR value of 5.0% from 2023 to 2028.
Growing awareness for early diagnosis of glaucoma have gained prominence due to various educational campaigns and screening programs. Early detection allows for timely intervention, leading to better disease management and reducing the risk of vision loss, thus propelling the market growth.…
Glaucoma Treatment Market - Safeguarding Sight: Innovating Glaucoma Treatment fo …
Newark, New Castle, USA: The "Glaucoma Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Glaucoma Treatment Market: https://www.growthplusreports.com/report/glaucoma-treatment-market/8926
This latest report researches the industry structure, sales, revenue,…
Glaucoma Surgical Devices Market By Device Type (Glaucoma Drainage Devices, Impl …
Glaucoma Surgical Devices market report presents a global overview of market shares, size, statistics, trends, demand, revenue and growth opportunities by key players, regions and countries. This report offers a complete market overview during the past, present, and the forecast period till 2032 which helps to identify future opportunities, risk factors, growing areas. Report also highlight on recent developments, technological innovations, market affecting factors, demographics analysis, demand and supply chain…
Micro-Invasive Glaucoma Implants Micro-Invasive Glaucoma Implants
Global Micro-Invasive Glaucoma Implants Market Definition: Micro-invasive glaucoma implants is performed for the treatment of the open- angle glaucoma and is done through an ab- interno approach. It is very safe and provides faster recovery as compared to the traditional methods. They usually lower the intraocular by increasing the flow or reducing the production of the aqueous humor. Increasing cases of the glaucoma worldwide is the major factor fueling the…
Glaucoma Surgery Devices Market 2016: Glaucoma Systems, Glaucoma Laser Devices
Latest industry research report on Glaucoma surgery devices are used in the glaucoma treating procedure. These procedures include both surgical and laser therapies performed on a patient. The cases of blindness due to glaucoma is on rise across the several countries. Furthermore, the demand for both technologically as well as advanced surgical equipment has resulted in the popularity of glaucoma surgery devices industry, worldwide.
Sudden increase in the aging population and…
